Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

California schools bar children without whooping cough shots

...

19 Sep 2011

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

NanoViricides, Inc. announced that Inno-Haven LLC has completed acquisition of a light industrial building. The Company anticipates that it will be leasing a portion of this space, in the near future, for laboratory facilities and cGMP production of its nanoviricides® drug candidates against various viral diseases.

19 Sep 2011

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

What should we eat? Answers abound in the international media, all of which rely on their interpretation of recent medical literature to come up with recommendations for the healthiest diet. But what if you could answer this question at a molecular level - what if you could find out how our genes respond to the foods we eat, and what this does to the cellular processes that make us healthy - or not? That's precisely what biologists at the Norwegian University of Science and Technology have done.

19 Sep 2011

Research roundup: Personalized info helps consumer decision-making; Racial disparities in knee replacement

Comparison Friction: Experimental Evidence From Medicare Drug Plans – Defining comparison friction as "the wedge between the availability of comparative information and consumers' use of it," the authors determined that providing prescription drug pricing information, even though it was free and accessible in other ways, increased the amount of "plan-switching" in the group to 28 percent compared to 17 percent in another that did not get the individual information.

17 Sep 2011

Additional data on safety, tolerability of Cempra's solithromycin to be presented at 51st ICAAC

Cempra Pharmaceuticals today announced abstracts to be presented on its fourth generation macrolide and novel fluoroketolide antibiotic, solithromycin (CEM-101), at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17 to 20, 2011, in Chicago. The abstracts provide additional data that demonstrate the safety and routes of administration of CEM-101, a new generation macrolide.

17 Sep 2011

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

Vaxin Inc., a clinical stage vaccine development company, today announced that it has been awarded a contract valued at up to $21.7 million by the Office of Biomedical Advanced Research and Development Authority (BARDA) for pre-clinical assessment, final manufacturing process development and the supply of clinical materials to support an IND filing and first-in-man dose ranging study of the company's proprietary anthrax vaccine, AdVAV.

17 Sep 2011

Georgia reminds adults to get vaccinated

Vaccines aren't just for kids, adults need protection too! September 18 kick starts National Adult Immunization Awareness Week and the Georgia Department of Public Health reminds Georgians that you never outgrow the need for vaccines.

16 Sep 2011

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

The advanced development of a novel next-generation anthrax vaccine and a new type of anthrax antitoxin have received support through new contracts funded the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority.

16 Sep 2011

New report finds improvements in hospital performance

Meanwhile, Reuters reports on the quality of weekend care at stroke centers and nursing homes are trying to reduce their use of powerful antipsychotic drugs for patients with dementia.

16 Sep 2011

Animals burn protein during long, cold hibernation

When Arctic ground squirrels are getting ready to hibernate they don't just get fat - they pack on muscle at a rate that would make a bodybuilder jealous. And they do it without suffering the harmful effects that high levels of testosterone and other anabolic steroids usually cause. University of Toronto Scarborough (UTSC) researchers have started to untangle how the squirrels manage it, and their results could someday have implications for human health.

16 Sep 2011

Teva to invest in CDI for development of novel antiviral drugs

Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.

16 Sep 2011

Burundi becomes 10th African country to protect children from pneumonia through immunisation

The Republic of Burundi will next week accelerate its fight against pneumonia, the world’s biggest killer of children under five, when it becomes the tenth African country to introduce new pneumococcal vaccines.

16 Sep 2011

Probiotics appear to protect against upper respiratory tract infections

Taking probiotics seems to provide both children and adults with a mild degree of protection against many upper respiratory tract infections (URTI) including the common cold, according to a new systematic review. People who consume probiotics are also less likely to end up taking antibiotics for an upper respiratory infection, the review found.

16 Sep 2011

Something like 'Contagion' could happen for influenza

In the new movie "Contagion," fictional health experts scramble to get ahead of a flu-like pandemic as a drug-resistant virus quickly spreads, killing millions of people within days after they contract the illness.

15 Sep 2011

First Edition: September 15, 2011

In today's news, reports about what might be included in President Obama's detailed plan to tame the federal federal budget. Here's a hint: Social Security changes are unlikely, but what about Medicare?

15 Sep 2011

Cempra's solithromycin demonstrates efficacy comparable to levofloxacin for CABP treatment

Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).

15 Sep 2011

Without action to curb antibiotic resistance, some diseases may once again become untreatable

In this Atlantic Magazine opinion piece, Megan McArdle, senior editor at the Atlantic, echoes a warning by the FDA issued in 2001 which stated, "Unless antibiotic resistance problems are detected as they emerge, and actions are taken to contain them, the world could be faced with previously treatable diseases that have again become untreatable, as in the days before antibiotics were developed."

15 Sep 2011

Roundup: Major Mass. health system, insurer near reimbursement deal; HHS funds Planned Parenthood in N.H.; 10 Iowa towns to get healthy

Partners HealthCare System Inc. is close to reaching an agreement with Blue Cross Blue Shield of Massachusetts that could provide relief to tens of thousands of insurance customers by slowing the rate of their premium increases, potentially by nearly a quarter of a billion dollars.

15 Sep 2011

ASM to honor LA BioMed investigator for A. baumannii infection study

Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.

14 Sep 2011

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in a Phase I clinical study of PENNVAX-B, its product for the prevention of the HIV sub-type prevalent in the US and Europe.

14 Sep 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

California schools bar children without whooping cough shots

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

Research roundup: Personalized info helps consumer decision-making; Racial disparities in knee replacement

Additional data on safety, tolerability of Cempra's solithromycin to be presented at 51st ICAAC

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

Georgia reminds adults to get vaccinated

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

New report finds improvements in hospital performance

Animals burn protein during long, cold hibernation

Teva to invest in CDI for development of novel antiviral drugs

Burundi becomes 10th African country to protect children from pneumonia through immunisation

Probiotics appear to protect against upper respiratory tract infections

Something like 'Contagion' could happen for influenza

First Edition: September 15, 2011

Cempra's solithromycin demonstrates efficacy comparable to levofloxacin for CABP treatment

Without action to curb antibiotic resistance, some diseases may once again become untreatable

Roundup: Major Mass. health system, insurer near reimbursement deal; HHS funds Planned Parenthood in N.H.; 10 Iowa towns to get healthy

ASM to honor LA BioMed investigator for A. baumannii infection study

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in